Login / Signup

Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity.

João Manuel SantosCamilla HeiniöVictor Cervera-CarrasconDafne C A QuixabeiraMikko SiuralaRiikka HavunenRalf ButzowSadia ZafarTanja de GruijlHeini LassusAnna KanervaAkseli E Hemminki
Published in: Journal for immunotherapy of cancer (2020)
Overall, oncolytic adenovirus Ad5/3-E2F-D24-hTNFa-IRES-hIL2 was able to rewire the ovarian tumor microenvironment to accommodate heightened antitumor TIL reactivity. Such effects may improve the clinical effectiveness of ACT with TILs in patients with advanced OVCA.
Keyphrases
  • randomized controlled trial
  • gene therapy
  • systematic review
  • peripheral blood